Skandinaviska Enskilda Banken AB »

Tg Therapeutics shares owned by Skandinaviska Enskilda Banken AB

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Skandinaviska Enskilda Banken AB from 13F filings

Historical chart of Skandinaviska Enskilda Banken AB investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Skandinaviska Enskilda Banken AB

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.8M 75k 23.39

More positions owned by Skandinaviska Enskilda Banken AB

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Abbvie (ABBV)
Merck & Co (MRK)
Tesla Motors (TSLA)

View all positions for Skandinaviska Enskilda Banken AB

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
BlackRock
State Street Corporation
Soleus Capital Management
Pictet Asset Management Holding SA
Geode Capital Management
Deep Track Capital
Woodline Partners
Susquehanna International
Opaleye Management
Goldman Sachs Group
Bank of America Corporation
Nuveen Asset Management
Morgan Stanley

View all funds holding Tg Therapeutics